Tracked deals
37
37 tracked deals across 2019-2026.
New York, New York, United States
Formerly known as APAC, Avista Capital Partners, Avista Public Acquisition Corp II (APAC)
New York-based private equity firm (founded in 2005) focused on investing in and building growth-oriented healthcare product and technology businesses. Avista partners with management teams to pursue healthcare specialization across multiple healthcare sub-sectors globally.
Tracked deals
37
37 tracked deals across 2019-2026.
Recent pace
8
8 tracked deals announced in the last 12 months.
Deal mix
Addon
18 addon · 14 buyout · 3 divestiture
Last 8 years
Supporting Data
Showing the 12 most recent of 37 tracked deals for Avista Healthcare Partners.
Avista Healthcare Partners (with strategic co-investor Damier Group) signed a definitive agreement to acquire Germany-based vitamins, minerals and supplements (VMS) platform sanotact Group GmbH. The deal also includes reinvestment by existing investor FLOTTE Beteiligungen GmbH, and expands Avista’s consumer healthcare exposure across manufacturing (CDMO) and branded supplement offerings.
Avista Healthcare Partners launched Birchwell Consumer Health as a new U.S. consumer healthcare platform focused on acquiring OTC and skincare brands. Birchwell’s first acquisition is Bag Balm, a Vermont-based therapeutic skincare brand acquired from a seller group led by Gemini Investors.
Avista Healthcare Partners acquired Bentec Medical, a Woodland, California manufacturer of complex silicone-based medical device components and finished goods. The deal was announced April 8, 2026, and financial terms were not disclosed.
PK Consumer Health, a portfolio company of Avista Healthcare Partners and Damier Group, has signed an agreement to acquire HealthAid Limited and HealthAid America Inc. HealthAid supplies VMS (vitamins, minerals, supplements) products to the independent pharmacy channel in the UK and US and is active in more than 50 countries via distributors. The transaction is expected to close in March 2026, with financial terms not disclosed.
WellSpring Consumer Healthcare, an Avista Healthcare Partners portfolio company, has acquired the DerMend and Recticare brands from Ferndale Pharma Group. The add-on expands WellSpring’s therapeutic skincare and OTC product portfolio and strengthens its omni-channel retail and e-commerce distribution; financial terms were not disclosed.
Vision Healthcare (an Avista Healthcare Partners portfolio company) has acquired Svenskt Kosttillskott, a leading Swedish e-commerce supplements retailer, and New Care Supplements BV, a Dutch nutraceutical brand. The add-on deals (New Care closed June 2025; Svenskt closed July 2025) strengthen Vision’s presence in the Netherlands and the Nordics and expand its D2C product offering and pan‑European distribution and digital capabilities; terms were not disclosed.
Avista Healthcare Partners completed its acquisition of PK Benelux, a leading Netherlands-based vitamins, minerals, and supplements (VMS) company known for the Lucovitaal brand. The deal strengthens Avista’s consumer health platform and supports continued growth in the Netherlands and broader Western European markets.
XiFin, a San Diego‑based healthcare IT company specializing in AI-enabled revenue cycle management, received a new growth capital investment led by a co-investment from Goldman Sachs External Investing Group alongside majority investor Avista Healthcare Partners and other institutional investors. The funding will accelerate development and adoption of the XiFin Empower platform; Jeff Margolis also joined XiFin's board. Financial terms were not disclosed.
Avista Healthcare Partners has acquired EBI, the bone healing division of Highridge Medical, marking Avista's 50th platform healthcare investment. The deal is a carve-out/divestiture from Highridge (a H.I.G. Capital portfolio company) intended to position EBI as a standalone leader in bone growth stimulation technologies.
GCM, a portfolio company of Avista Healthcare Partners, acquired the assets of Precision Swiss Products (PSP), adding a state-of-the-art 50,000+ sq ft manufacturing facility in Wilmington, North Carolina. The asset purchase expands GCM's precision machining and micro-feature manufacturing capabilities and broadens its customer access across medical device, aerospace and semiconductor capital equipment markets.
Avista Healthcare Partners has completed the acquisition of Trillium Health Care Products, a Brockville, Ontario-based CDMO specializing in branded over‑the‑counter (OTC) products, from New Water Capital. Avista plans to invest in Trillium’s growth, expand its footprint and capabilities, and use the business as a consumer‑healthcare platform for potential strategic add‑on acquisitions.
WellSpring Consumer Healthcare, a portfolio company of Avista Healthcare Partners, has acquired the vH essentials women's intimacy care OTC brand from Wisconsin Pharmacal Company. The add-on expands WellSpring's women's health franchise alongside FDS to drive scale and accelerate growth across retail and e-commerce channels; financial terms were not disclosed.
Turn tracked acquisition activity into an outreach-ready buyer list.